You are here: Industry Insights > COVID-19 Vaccine

News List

Elicio’s lymph node targeting candidate joins Covid-19 vaccine race pharmaceutical-technology
August 21, 2020
Elicio Therapeutics has reported promising findings from preclinical studies of ELI-005, a protein subunit, lymph node targeting Covid-19 vaccine candidate.
EU, CureVac may sign deal for 225 million doses of COVID-19 vaccine expresspharma
August 21, 2020
CureVac said it could start large-scale human trials on its vaccine in the last quarter of this year based on results of its current trials.
CUNY med school, TechnoVax report COVID-19 vaccine breakthrough prnewswire
August 20, 2020
The CUNY School of Medicine at The City College of New York and TechnoVax, Inc., a biotechnology developer of novel vaccines, announce a breakthrough in their collaborative effort to develop a vaccine for COVID-19.
Australia signs deal for AstraZeneca’s Covid-19 vaccine pharmaceutical-technology
August 20, 2020
The Australian Government has signed an agreement with AstraZeneca for the supply of the company’s Covid-19 vaccine candidate developed by the University of Oxford.
Emergency authorisation for COVID-19 vaccine possible if government decides: ICMR expresspharma
August 20, 2020
A top ICMR official told a parliamentary panel that phase-two clinical trials of two indigenously developed COVID-19 vaccine candidates have almost been completed and emergency authorisation of a vaccine could be considered if the Centre decides so.
AstraZeneca Concludes Agreement with EC for COVID-19 Vaccine americanpharmaceuticalreview
August 19, 2020
AstraZeneca has concluded an agreement with the European Commission (EC) to supply up to 400 million doses of the AZD1222 COVID-19 vaccine.
Pakistan to conduct phase-III clinical trial of COVID-19 vaccine from CanSinoBio expresspharma
August 19, 2020
The NIH said this would be the first-ever phase-III clinical trial for any vaccine in Pakistan.
Brazil regulator gives approval for human trials of J&J COVID-19 vaccine candidate expresspharma
August 19, 2020
Brazil’s health regulator Anvisa has approved human clinical trials for a potential COVID-19 vaccine developed by Johnson & Johnson’s pharma subsidiary Janssen.
EC and UK sign agreements for Covid-19 vaccines supply pharmaceutical-technology
August 18, 2020
The European Commission (EC) and the UK Government have entered into separate agreements for the supply of potential Covid-19 vaccines.
OSE’s Covid-19 vaccine shows promise in preclinical studies pharmaceutical-technology
August 18, 2020
OSE Immunotherapeutics has reported positive data from preclinical and human ex-vivo studies of its Covid-19 vaccine candidate, CoVepiT.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page